IGEA S.p.A

IGEA Researches the Clinical Application of Physical Stimuli in Biological Systems.IGEA's mission is to improve patients' quality of life by developing and producing innovative, effective, and safe treatment systems for clinical practice.IGEA develops biophysical therapies in two main areas: 1. Orthopedics: enhancing bone healing and joint preservation. 2. Oncology: cancer treatment.IGEA is a global leader in electrochemotherapy. Electrochemotherapy is a minimally invasive therapy that combines low doses of chemotherapy drugs with specific multiple or single electrodes delivering electric pulses (electroporation) directly to cancer cells.Cliniporator® and Cliniporator®VITAE are state-of-the-art electroporation technologies used to treat tumor nodules located in the skin, subcutaneous tissue, parenchyma, and bone.